Copyright
©The Author(s) 2018.
World J Clin Cases. Nov 6, 2018; 6(13): 600-610
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Figure 3 Serum iron markers among hepatocellular carcinoma patients with different Barcelona Clinic Liver Cancer stages.
A: Hepcidin; B: Serum iron; C: Serum ferritin; D: Transferrin; E: Transferrin saturation; F: Total iron binding capacity. aP < 0.05 vs Stage A; bP < 0.05 vs Stage B; cP < 0.05 vs Stage C; dP < 0.05 vs Stage D. Stage A: Stage A of BCLC; Stage B: Stage B of BCLC; Stage C: Stage C of BCLC; Stage D: Stage D of BCLC.
- Citation: Gao YH, Wang JY, Liu PY, Sun J, Wang XM, Wu RH, He XT, Tu ZK, Wang CG, Xu HQ, Niu JQ. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World J Clin Cases 2018; 6(13): 600-610
- URL: https://www.wjgnet.com/2307-8960/full/v6/i13/600.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i13.600